Page 1 of Clinical Trials for First-line treatment of metastatic hormone-refractory prostate cancer SUTENT in combination with docetaxel and prednisone, 1 Total Matches
- 1CompletedLast Updated: August 25, 2011Condition(s): Prostatic Neoplasms
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=First-line+treatment+of+metastatic+hormone-refractory+prostate+cancer+SUTENT+in+combination+with+docetaxel+and+prednisone
